1. Receive a 1-2 page summarized information on the study recommended by your Neurologist to take home and review. If you are willing to participate, you will be contacted by the Study sponsor for the Informed consent which is critical for a good clinical trial, so even if you are sure that you would like to do the study, you must take the information review it before you can sign up. The Informed Consent Form will include answers to the following questions:
- What is the purpose of the clinical trial?
- How long will the trial last?
- What is required of you to participate in this study?
- What treatments or drugs will you receive during the trial?
- What treatments, tests and/or procedures will be required during the study? How many and how often?
- Which treatments, tests, medications and/or procedures will be paid for?
- What are the risks and benefits of participating in the study?
- What treatment would be recommended for you if you do not participate in the trial?
Discuss with the research sponsor nurse who will review the contents of the form with you and show you the areas on the form that you need to sign.
After the research nurse registers you with the study, you will be randomly selected for either a “control” group that receives the standard treatment or a “trial” group that receives the new treatment. Cancer patients are always given a treatment and never administered a placebo (sugar-pill). Instead, the tested treatment is compared to current treatments. In some instances, you will not know which group you are in, and neither will your doctors or the researchers, until the study is over. In other instances, you along with your doctors and the researchers will know exactly what you are receiving.
Participation in clinical trials is always voluntary.
You will never be enrolled in a clinical trial without your permission, and you can change your mind about participating in the clinical trial at any time after signing the informed consent forms. To stop participation in a study, simply talk to your research team. Results can vary for individuals involved in a clinical trial. Participants enrolled in clinical trials must have clear and realistic expectations based on their individual health status and diagnosis.
Our neurologists currently have recommended trial for the early onset of Alzheimer’s and Parkinson’s Dementia, and Epilepsy.
Previously, we were among the few sites in the U.S. to provide our patients with the orphan drug Droxidopa as it awaits final FDA approval and commercial availability.
Various new and exciting clinical research trials are under review and will be added as we continually strive to bring to you the best and safest studies.
For more information, please call (281) 425-3805